Marrone Bio (MBII)
NASDAQ:MBII

Marrone Bio Stock Analysis & Ratings

MBII Stock Chart & Stats

Day’s Range$1.03 - $1.07
52-Week Range$0.55 - $1.95
Previous Close$1.06
Volume50.07K
Average Volume (3M)907.38K
Market Cap$158.34M
P/E Ratio-11.2
Beta0.35
Next EarningsAug 15, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score3
EPS (TTM)-0.09


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

MBII FAQ

What was Marrone Bio’s price range in the past 12 months?
Marrone Bio lowest stock price was $0.55 and its highest was $1.95 in the past 12 months.
    What is Marrone Bio’s market cap?
    Marrone Bio’s market cap is $158.34M.
      What is Marrone Bio’s price target?
      The average price target for Marrone Bio is $1.30. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $1.30 ,the lowest forecast is $1.30. The average price target represents 22.64% Increase from the current price of $1.06.
        What do analysts say about Marrone Bio?
        Marrone Bio’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
          When is Marrone Bio’s upcoming earnings report date?
          Marrone Bio’s upcoming earnings report date is Aug 15, 2022 which is in 87 days.
            How were Marrone Bio’s earnings last quarter?
            Marrone Bio released its earnings results on May 11, 2022. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of -$0.017 by -$0.023.
              Is Marrone Bio overvalued?
              According to Wall Street analysts Marrone Bio’s price is currently Undervalued.
                Does Marrone Bio pay dividends?
                Marrone Bio does not currently pay dividends.
                What is Marrone Bio’s EPS estimate?
                Marrone Bio’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Marrone Bio have?
                Marrone Bio has 149,370,000 shares outstanding.
                  What happened to Marrone Bio’s price movement after its last earnings report?
                  Marrone Bio reported an EPS of -$0.04 in its last earnings report, missing expectations of -$0.017. Following the earnings report the stock price went up 1.042%.
                    Which hedge fund is a major shareholder of Marrone Bio?
                    Among the largest hedge funds holding Marrone Bio’s share is Ardsley Advisory Partners. It holds Marrone Bio’s shares valued at 20M.

                      ---

                      Marrone Bio Stock Analysis

                      Smart Score
                      3
                      Underperform
                      1
                      2
                      3
                      4
                      5
                      6
                      7
                      8
                      9
                      10
                      Price Target
                      $1.30
                      ▲(22.64% Upside)
                      Moderate Buy
                      The Marrone Bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Marrone Bio

                      Marrone Bio Innovations, Inc. engages in the provision of bio-based pest management and plant health products for the agricultural and water treatment markets. Its brand includes regalia, bio-tam, grandevo, venerate and majestene. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Davis, CA.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      FMC
                      American Vanguard
                      SenesTech
                      Scotts Miracle-Gro Company

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis